Skip to main content
. 2022 Jan 18;10(2):564–576. doi: 10.1002/fsn3.2682

TABLE 1.

Key pathways and the major DEGs in these pathways related to inflammation

Pathway Key DEGs from the pathway
IL vs. AIL IL vs. PIL IL vs. BIL
PI3K‐Akt signaling pathway TLR2, NFKB1, PI3KCG, F2R TLR2, SYK, JAK1, PIK3CG, PIK3CA_B_D, AKT, NFKB1, RAF1 TLR2, SYK, JAK1, PIK3CG, PIK3CA_B_D, AKT, ERK, NFKB1, RAF1,
JAK‐STAT signaling pathway STAT1, IL−2, SOCS1, AOX JAK1, STAT1, AKT, SOCS1, AOX, IL−2, RAF1 IL−2, JAK1, STAT1, AKT, AOX, SOCS1, RAF1
NF‐κB signaling pathway IL−1B, IL−1R1, CD14, VCAM1, NFKB1, IRAK1, CCL21 IL−1R1, IL−1B, SYK, CD14, TLR4, NFKB1, CCL4, CXCL2, CCL21, COX2(PTGS2), IRAK1 IL−1R1, IL−1B, CD14, TLR4, SYK, NFKB1, COX2, CCL4, CXCL2, CCL21, IRAK1
MAPK signaling pathway NFKB1, IL−1R1, CD14, MAP3K6, IRAK1 NFKB1, JNK, AKT, IL−1A, IL−1R1, IRAK1, CD14, RAF1, MAP3K6, MAP3K5, MAP2K7 CD14, IL−1A, IL−1R1, IRAK1, HRAS, RAF1, ERK, NFKB1, AKT, MAP3K6, MAP3K5, MAP3K1, MAP2K7, JNK